Filter Results:
(619)
Show Results For
- All HBS Web
(619)
- People (4)
- News (103)
- Research (424)
- Events (3)
- Multimedia (4)
- Faculty Publications (261)
Show Results For
- All HBS Web
(619)
- People (4)
- News (103)
- Research (424)
- Events (3)
- Multimedia (4)
- Faculty Publications (261)
- 29 Jan 2013
- First Look
First Look: Jan. 29
facing the scientific founder and CEO of a promising, early stage bio-pharmaceuticals company. Should the company establish a proposed alliance with a pharmaceutical firm? Should it create a nutraceuticals... View Details
Keywords: Sean Silverthorne
- 18 Dec 2012
- First Look
First Look: December 18
pharmaceutical company GSK must choose how much to integrate a recently acquired biotechnology firm, Sirtris. Moncef Slaoui, GSK's global head of R&D, championed the acquisition of Sirtris to gain access... View Details
Keywords: Carmen Nobel
- 01 Jun 2011
- News
The Best-Laid Plans
Finale’s original lead investors acquired a majority ownership in the business, folding it into a Rhode Island–based holding company where Conforti now serves as managing partner of the restaurant group. “When I started Finale, I... View Details
- 02 Mar 2010
- First Look
First Look: March 2
innovation in a wide range of other industries, including pharmaceuticals and biotechnology, IT and telecommunications, defense, chemicals, and agriculture. We believe that there are valuable lessons in this research for the energy... View Details
Keywords: Martha Lagace
- 12 Oct 2006
- First Look
First Look: October 12, 2006
Protection Agency (US EPA) program that encourages companies to self-disclose violations of environmental laws and regulations in exchange for reduced sanctions. We find that facilities are more likely to self-disclose if they were... View Details
Keywords: Sean Silverthorne
- 20 Feb 2018
- First Look
First Look at New Research and Ideas, February 20, 2018
new fund. Purchase this case: https://cb.hbsp.harvard.edu/cbmp/product/317036-PDF-ENG Harvard Business School Case 118-052 Charity or Bribery? Filip Kowalski, a senior manager at the pharmaceutical company... View Details
Keywords: Sean Silverthorne
- 03 Jan 2017
- First Look
January 3, 2017
silos within numerous academic medical centers, pharmaceutical companies, and some disease-based foundations. For new precision therapies to be developed, these data sets need to be shared broadly. Patients can help lead this effort by... View Details
Keywords: Carmen Nobel
- 07 Apr 2003
- Research & Ideas
XTV: Xerox’s Attempted Recovery From “Fumbling the Future”
with researchers at PARC. Much of that time was occupied with interviewing prospective customers who had significant problems with document management. For example, a pharmaceutical company that was applying... View Details
Keywords: by Henry Chesbrough
- 12 Jul 2021
- News
Alumni Confront the COVID-19 Crisis
the availability of critical resources, and the efficacy of both pharmaceutical and non-pharmaceutical interventions. The company has created a set of free publicly available visual analytic dashboards. "The... View Details
- 03 Mar 2009
- First Look
First Look: March 3, 2009
challenges involved in developing and executing the new service model and offers students opportunities to discuss the evolving challenges the company faces looking forward. Purchase this case:... View Details
Keywords: Martha Lagace
- 01 Sep 2014
- News
All For One
breath, then begins to recount her first excited trips to unlock the paradox of what made Pixar special. At the time, the company was in the midst of producing the movie Ratatouille—an unlikely story about a rat in Paris who yearns to be... View Details
- 10 Jan 2005
- Research & Ideas
Motivation and the Cross-Sector Alliance
The first question focuses on motivations, while the second one has more to do with the benefits sought in interactions with future partners. Altruism As a general rule, collaboration efforts between companies and CSOs have an inherent... View Details
- 19 Jan 2023
- News
Forged in Fire
Subscribe on iTunes Subscribe on Spotify More Skydeck episodes Hi, this is Dan Morrell, host of Skydeck. When he was just three years old, Chad Foster (PLDA 21, 2016) was diagnosed with retinitis pigmentosa, a degenerative condition that would ultimately leave him... View Details
- 01 Sep 2014
- News
Afghanistan’s Hope and Light
considerably. He went on to earn advanced degrees in biochemistry and management science and immigrated with his new wife, Shainoor, to Vancouver. After a brief stint at a pharmaceutical company (“I’m an... View Details
Keywords: Julia Hanna
- 03 Nov 2015
- First Look
November 3, 2015
quantify the impact of scientific grant funding at the National Institutes of Health (NIH) on patenting by pharmaceutical and biotechnology firms. Our paper makes two contributions. First, we use newly constructed bibliometric data to... View Details
Keywords: Sean Silverthorne
- 03 Feb 2015
- First Look
First Look: February 3
architecture, including business- and technology-related aspects. We apply our methodology to data gathered in a large pharmaceutical firm. We show that this methodology helps to identify layers in the firm's architecture associated with... View Details
Keywords: Sean Silverthorne
- 28 May 2008
- First Look
First Look: May 28, 2008
goals? Purchase the case: http://www.hbsp.harvard.edu/b01/en/common/item_detail.jhtml?id=308030 Can PACIV (Puerto Rico) Serve European Customers? Harvard Business School Case 808-099 Jorge Rodriguez-Gonzalez, PACIV's (Puerto Rico) founding CEO, is considering expanding... View Details
Keywords: Martha Lagace
- 24 Feb 2009
- First Look
First Look: February 24, 2009
http://www.hbsp.harvard.edu/b01/en/common/item_detail.jhtml?id=909036 Esser & Ackermann at Mannesmann Harvard Business School Case 209-095 No abstract is available at this time. Purchase this case:... View Details
Keywords: Martha Lagace
- 01 Dec 2001
- News
Reaching Out
Ph.D. in pathology and molecular biology at Boston University's School of Medicine. Intrigued by his experience with pharmaceutical companies and the role of business in drug delivery, he enrolled at HBS one... View Details
- 01 Dec 2010
- News
This Is What I Do
thus deserve our support.” The MJFF raises about $50 million a year. There are prominent backers, such as Google’s Sergey Brin and his wife, Anne Wojcicki, but nearly 55,000 other people made contributions last year. To date the MJFF has supported about ninety biotech... View Details